CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 215 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,123,693 | -43.1% | 39,197 | -26.3% | 0.01% | -18.2% |
Q1 2024 | $3,730,904 | -44.3% | 53,215 | -33.6% | 0.01% | -50.0% |
Q4 2023 | $6,692,308 | +220.2% | 80,157 | +13.0% | 0.02% | +175.0% |
Q3 2023 | $2,089,804 | +0.8% | 70,937 | +11.6% | 0.01% | +14.3% |
Q2 2023 | $2,073,556 | -1.7% | 63,567 | +6.0% | 0.01% | -12.5% |
Q1 2023 | $2,110,379 | -23.2% | 59,971 | 0.0% | 0.01% | -20.0% |
Q4 2022 | $2,747,871 | +8.5% | 59,971 | +14.7% | 0.01% | 0.0% |
Q3 2022 | $2,533,000 | +12.8% | 52,282 | -8.5% | 0.01% | +11.1% |
Q2 2022 | $2,245,000 | -18.7% | 57,136 | -23.8% | 0.01% | 0.0% |
Q1 2022 | $2,761,000 | -11.9% | 75,013 | +9.1% | 0.01% | 0.0% |
Q4 2021 | $3,133,000 | -0.1% | 68,738 | -21.7% | 0.01% | -10.0% |
Q3 2021 | $3,137,000 | +52.8% | 87,761 | -15.4% | 0.01% | +42.9% |
Q2 2021 | $2,053,000 | -15.0% | 103,762 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $2,414,000 | +16.9% | 103,762 | +8.8% | 0.01% | 0.0% |
Q3 2020 | $2,065,000 | – | 95,388 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |